==== Front Ann Saudi MedAnn Saudi MedAnnals of Saudi Medicine0256-49470975-4466King Faisal Specialist Hospital and Research Centre 10.5144/0256-4947.2006.407asm-5-407LettersLung involvement in inflammatory bowel diseases Sarıoğlu Nurhan *Türkel Nurten †Şakar Ayşın *Çelik Pınar *Saruç Murat †Demir M. Akif ‡Göktan Cihan §Kırmaz Cengiz ||Yüceyar Hakan †Yorgancıoğlu Arzu * * Celal Bayar University Medical School Department of Pulmonology, Manisa, Turkey, 1785 sok. No: 61/9 35540 Karşıyaka-Izmir, Turkey † Celal Bayar University Medical School Department of Gastroenterology, Manisa, Turkey, 1785 sok. No: 61/9 35540 Karşıyaka-Izmir, Turkey ‡ Celal Bayar University Medical School Department of Pathology, Manisa, Turkey, 1785 sok. No: 61/9 35540 Karşıyaka-Izmir, Turkey § Celal Bayar University Medical School Department of Radiology, Manisa, Turkey, 1785 sok. No: 61/9 35540 Karşıyaka-Izmir, Turkey || Celal Bayar University Medical School Department of Allergy and Immunology, Manisa, Turkey, 1785 sok. No: 61/9 35540 Karşıyaka-Izmir, Turkey, T: +90-236-232 3133, F: +90-236-232 8492, aysins@hotmail.com, aysin.sakar@bayar.edu.trSep-Oct 2006 26 5 407 408 Copyright © 2006, Annals of Saudi Medicine2006This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. ==== Body To the Editor: The rate of extraintestinal involvement in inflammatory bowel diseases (IBD) was reported as 21% to 41%.1 Pulmonary involvement patterns include tracheobronchitis, tracheal stenosis, bronchitis, bronchiectasis, interstitial lung disease, necrobiotic nodule, serositis, and pulmonary vasculitis.2,3,4,5,6,7 Our aim was to evaluate lung involvement in IBD. Seventeen IBD patients were included in the study with the approval of a local ethics committee. IBD activity was evaluated by clinical, endoscopic, and histopathological findings. Patients with a previous history of lung disease were excluded. Pulmonary function tests (PFT) were carried out using a Jaeger Master Screen Pneumo device. Patients with normal PFT values were examined for bronchial hyperreactivity with methacholine. High-resolution computed tomography (HRCT) was obtained using a Siemens Emotion 2003 Spiral CT (Munich, Germancy) device. Fiberoptic bronchoscopy was applied to 15 of 17 patients who accepted the procedure. Bronchoalveolar lavage (BAL) was performed by standard technique. Mucosal biopsies were also taken from the middle lobe through the lower lobe carina on the right, and the upper lobe through the lingua carina on the left. SPSS software was used for the analysis of the data. Fisher’s exact test was used for comparison of disease activity to other parameters. Of the 17 patients, 15 had ulcerative colitis and 2 had Crohn’s disease. The mean age of 10 female (58.8%) and 7 male (41.2%) cases was 41.0±12.5 years and the mean duration of disease was 5.6±5.9 years. Six of the cases were regarded as active IBD. Respiratory symptoms were observed in 4 (23%) cases. PFT parameters were normal in all patients except one, who had restriction. Bronchial hyperreactivity was positive in 5 cases irrespective of respiratory symptoms. HRCT revealed pathology (air-trapping, emphysema, peribronchial thickening, bronchectasis, fibrosis, frosted glass, bullae) in 15 cases (88.2%). In BAL, the cell count of 7 cases (46,6%) indicated alveolitis (lymphocytic 40% and neutrophilic 6.6%) was present whereas in the mucosal biopsy of 2 cases (11.8%), submucosal inflammatory cell infiltration was observed. No relationship was found between disease activity and thorax HRCT findings, PFT, and BAL values (P=0.5). Despite the amount of research carried out on extraintestinal findings in IBD, the pathogenesis still needs clarification. In such diseases, since there is an impairment in the mucosal immune regulation of gastrointestinal system antigens, digestive enzymes, and bacteria in the luminal content; activation of immune regulatory cells by the systemic circulation occurs.8 Respiratory system pathologies can be classified as airway disease (upper airway obstruction, acute bronchitis, chronic bronchitis, chronic bronchial suppuration, bronchiectasis, bronchiolitis), parenchymal disease (cryptogenic organising pneumonia, pulmonary infiltrates and peripheral eosinophilia, interstitial lung disease, necrotic nodule), and serositis (pleural effusion, pericarditis, pleuropericarditis, myocarditis).2 Respiratory pathologies generally arise after diagnosis of IBD. However, they may arise simultaneously or previously.9 Abnormalities of PFT in IBD are not so common. Obstructive and restrictive disorders and bronchial hyperreactivity can be observed.2,4,10,11,12 These findings become obvious especially in the activation period of the disease. A restrictive disorder was present in only one (5%) of our patients. However, the majority (64%) of our patients were in a remission period. Bronchial hyperreactivity in the range of 17% to 45% was detected in different studies.13,14 We detected hyperreactivity in 29% of our cases. Abnormalities such as bronchiectasis, air-trapping, tree-in-bud appearance, and ground glass opacity may be observed in HRCT even when there is no respiratory symptoms in IBD.4,9,10 Songur et al found no relationship between HRCT pathologies and PFT.7 Our study also yielded no correlation between HRCT pathologies and PFT. Alveolitis may be lymphocytic, neutrophilic, or eosinophilic according to the presence of bronchiectasis, associated granulomatous disorders, drug usage and smoking.4,15,16 Our study demonstrated lymphocytic and neutrophilic alveolitis in 40% and 6.6%, respectively. Ground glass opacity, neutrophilic alveolitis, and restrictive-type PFT were observed all together in one patient. Tracheobronchial involvement has been defined in tracheal mucosa biopsies of patients with Crohn’s disease.6 Tracheobronchitis may be an extraintestinal manifestation of Crohn’s disease and it responds very well to inhaled budesonide therapy. Camus et al have shown an intense infiltration of lymphocyte and plasma cells in mucosa biopsies.9 Karadag et al have identified lymhocyte infiltration, fibrosis and thickening in alveolar septas.4 Submucosal inflammatory cell infiltation was identified in 2 of our cases. In conclusion, there was no relationship between the radiological and hystopathological findings of the respiratory system in IBD patients. In our study, this may be due to the small number of cases. However, even in the absence of respiratory symptoms, cases with IBD should be evaluated for pulmonary involvement because extraintestinal involvement is frequently observed in IBD. ==== Refs References 1 Storch I Sachar D Katz S Pulmonary manifestations of inflammatory bowel disease Inflamm Bowel Dis 2003 9 2 104 115 12769444 2 Shepertycky M Sciberras D Sharma S Lung involvement in inflammatory bowel disease: A case report and review of literature Clinical Pulmonary Medicine 2004 11 2 92 100 3 Casey MB Tazelaar HD Myers JL Hunninghake GW Kakar S Kalra SX Noninfectious lung pathology in patients with Crohn’s disease Am J Surg Pathol 2003 27 2 213 219 12548168 4 Karadag F Ozhan MH Akcicek E Gunel O Alper H Veral A Is it possible to detect ulcerative colitis-related respiratory syndrome early? Respirology 2001 6 341 346 11844126 5 Kraft SC Earle RH Rossler M Esterly JR Unexplained bronchopulmonary disease with inflammatory bowel disease Arc Intern Med 1976 136 454 459 6 West JE Adair NE Tracheobronchitis associated with Crohn’s disease J Bronchol 2004 11 194 197 7 Songur N Songur Y Tuzun M Dogan I Tuzun D Ensari A Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease J Clin Gastroenterol 2003 37 292 298 14506385 8 Şahan C Pulmonary involvement in inflammatory bowel disease Guncel Gastroenteroloji 2003 7 2 141 145 (Turkish) 9 Camus P Piard F Ashcroft T Gal AA Colby TV The lung in inflammatory bowel disease Medicine 1993 72 151 183 8502168 10 Mahadeva R Walsh G Flower CDR Shneerson JM Clinical and radiological characteristics of lung disease in inflammatory bowel disease Eur Respir J 2000 15 41 48 10678619 11 Douglas JG McDonald CF Leslie MJ Gillon J Crompton GK McHardy GJ Respiratory impairment in inflammatory bowel disease: does it vary with disease activity Respir Med 1989 83 389 394 2616823 12 Kuzela L Vavrecka A Prikazska M Drugda B Hronec J Senkova A Pulmonary complications in patients with inflammatory bowel disease Hepatogastroenterology 1999 46 1714 1719 10430329 13 Ceyhan BB Karakurt S Cevik H Sungur M Bronchial hyperreactivity and allergic status in inflammatory bowel disease Respiration 2003 70 1 60 66 12584393 14 Louis E Louis R Drion V Bonnet V Lamproye A Radermecker M Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease Allergy 1995 50 729 733 8546267 15 Bonniere P Wallaert B Cortot A Marchandise X Riou Y Tonnel AB Latent pulmonary involvement in Crohn’s disease: biological, functional, bronchoalveolar lavage and scintigraphic studies Gut 1986 27 919 925 3015749 16 Wallaert B Colombel JF Tonnel AB Bonniere P Cortot A Paris JC Evidence of lymphocyte alveolitis in Crohn’s disease Chest 1985 87 363 367 3971763